India seeks more data for emergency AstraZeneca shot approval

By Nivedita Bhattacharjee BENGALURU (Reuters) - India's drugs regulator said https://cdsco.gov.in/opencms/opencms/system/modules/CDSCO.WEB/elements/common_download.jsp?num_id_pk=MTI3NQ== on Wednesday it had sought more data to make a decision on emergency authorisation for AstraZeneca's COVID-19 vaccine candidate and one developed locally by Bharat Biotech and the government. India, which is the world's biggest vaccine-maker, has said it may authorise some shots in the coming weeks, and experts at the country's Central Drugs Standard Control Organization (CDSCO) met under an 'accelerated approval process' to discuss the applications that were made only this week. The regulator said it had asked the Serum Institute of India, which is the local manufacturer of the AstraZeneca vaccine, to present updated safety data from its ongoing third-stage trial in the country.

Reuters December 10, 2020 00:06:24 IST
India seeks more data for emergency AstraZeneca shot approval

India seeks more data for emergency AstraZeneca shot approval

By Nivedita Bhattacharjee

BENGALURU (Reuters) - India's drugs regulator said https://cdsco.gov.in/opencms/opencms/system/modules/CDSCO.WEB/elements/common_download.jsp?num_id_pk=MTI3NQ== on Wednesday it had sought more data to make a decision on emergency authorisation for AstraZeneca's COVID-19 vaccine candidate and one developed locally by Bharat Biotech and the government.

India, which is the world's biggest vaccine-maker, has said it may authorise some shots in the coming weeks, and experts at the country's Central Drugs Standard Control Organization (CDSCO) met under an "accelerated approval process" to discuss the applications that were made only this week.

The regulator said it had asked the Serum Institute of India, which is the local manufacturer of the AstraZeneca vaccine, to present updated safety data from its ongoing third-stage trial in the country.

It has also asked for immunogenicity data from clinical trials in the UK and India, and for the British authorities' assessment of its emergency-use request there.

Bharat Biotech will also have to provide safety and efficacy data from its vaccine candidate's ongoing Phase III clinical trials in India for further consideration. The company had only presented data from the initial trials.

The Serum Institute did not respond to requests for comment. Bharat Biotech declined to comment.

The CDSCO said Pfizer Inc, which was the first company to seek emergency use authorisation in India through an application on Saturday, had sought more time to make a presentation before it.

The regulator also recommended Phase I/II trials for a vaccine candidate developed by Gennova Biopharmaceuticals Ltd, based in the western Indian city of Pune. It will be the ninth vaccine candidate that the country could manufacture.

A source with direct knowledge of the matter told Reuters that a decision on emergency use would be taken "in toto" and it was too early to say whether the vaccines being considered would be rejected or accepted.

India has reported nearly 10 million COVID-19 infections, putting it behind the United States globally in overall cases.

(Reporting by Nivedita Bhattacharjee, Krishna N. Das, Chandini Monappa and Abhirup Roy; Editing by Andrew Heavens and Alexander Smith)

This story has not been edited by Firstpost staff and is generated by auto-feed.

Updated Date:

TAGS:

also read

France, Germany to agree to NATO role against Islamic State - sources
| Reuters
World

France, Germany to agree to NATO role against Islamic State - sources | Reuters

By Robin Emmott and John Irish | BRUSSELS/PARIS BRUSSELS/PARIS France and Germany will agree to a U.S. plan for NATO to take a bigger role in the fight against Islamic militants at a meeting with President Donald Trump on Thursday, but insist the move is purely symbolic, four senior European diplomats said.The decision to allow the North Atlantic Treaty Organization to join the coalition against Islamic State in Syria and Iraq follows weeks of pressure on the two allies, who are wary of NATO confronting Russia in Syria and of alienating Arab countries who see NATO as pushing a pro-Western agenda."NATO as an institution will join the coalition," said one senior diplomat involved in the discussions. "The question is whether this just a symbolic gesture to the United States

China's Xi says navy should become world class
| Reuters
World

China's Xi says navy should become world class | Reuters

BEIJING Chinese President Xi Jinping on Wednesday called for greater efforts to make the country's navy a world class one, strong in operations on, below and above the surface, as it steps up its ability to project power far from its shores.China's navy has taken an increasingly prominent role in recent months, with a rising star admiral taking command, its first aircraft carrier sailing around self-ruled Taiwan and a new aircraft carrier launched last month.With President Donald Trump promising a US shipbuilding spree and unnerving Beijing with his unpredictable approach on hot button issues including Taiwan and the South and East China Seas, China is pushing to narrow the gap with the U.S. Navy.Inspecting navy headquarters, Xi said the navy should "aim for the top ranks in the world", the Defence Ministry said in a statement about his visit."Building a strong and modern navy is an important mark of a top ranking global military," the ministry paraphrased Xi as saying.